201 related articles for article (PubMed ID: 33715575)
1. Intrauterine Growth Retardation is a Risk Factor for Anthracycline Toxicity.
Eroglu N; Yoldas T; Bilgin B; Yesil S; Fettah A; Sahin G
Pediatr Hematol Oncol; 2021 Aug; 38(5):497-503. PubMed ID: 33715575
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of long-term cardiac side effects of anthracycline chemotherapy by conventional and non-conventional echocardiographic methods in childhood cancer survivors.
Yoldaş T; Yeşil Ş; Karademir S; Şahin G; Arman Örün U; Doğan V; Özgür S
Cardiol Young; 2019 Jul; 29(7):904-909. PubMed ID: 31218970
[TBL] [Abstract][Full Text] [Related]
3. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
[TBL] [Abstract][Full Text] [Related]
4. Left ventricle segmental function in childhood cancer survivors using speckle-tracking echocardiography.
Akam-Venkata J; Kadiu G; Galas J; Lipshultz SE; Aggarwal S
Cardiol Young; 2019 Dec; 29(12):1494-1500. PubMed ID: 31771663
[TBL] [Abstract][Full Text] [Related]
5. Use of speckle tracking echocardiography to detect late anthracycline-induced cardiotoxicity in childhood cancer: A prospective controlled cross-sectional study.
Amedro P; Vincenti M; Abassi H; Lanot N; De La Villeon G; Guillaumont S; Gamon L; Mura T; Lopez-Perrin K; Haouy S; Sirvent A; Cazorla O; Vergely L; Lacampagne A; Avesani M; Sirvent N; Saumet L
Int J Cardiol; 2022 May; 354():75-83. PubMed ID: 35167907
[TBL] [Abstract][Full Text] [Related]
6. Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis.
Kang Y; Xiao F; Chen H; Wang W; Shen L; Zhao H; Shen X; Chen F; He B
Arq Bras Cardiol; 2018 Mar; 110(3):219-228. PubMed ID: 29694546
[TBL] [Abstract][Full Text] [Related]
7. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G
BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778
[TBL] [Abstract][Full Text] [Related]
8. Late cardiotoxic effects of anthracycline chemotherapy in childhood malignancies.
Roodpeyma S; Moussavi F; Kamali Z
J Pak Med Assoc; 2008 Dec; 58(12):683-7. PubMed ID: 19157322
[TBL] [Abstract][Full Text] [Related]
9. Two- and three-dimensional myocardial strain imaging in the interrogation of sex differences in cardiac mechanics of long-term survivors of childhood cancers.
Li VW; Liu AP; So EK; Ho KK; Yau JP; Cheuk DK; Cheung YF
Int J Cardiovasc Imaging; 2019 Jun; 35(6):999-1007. PubMed ID: 30848401
[TBL] [Abstract][Full Text] [Related]
10. New insight into the intraventricular pressure gradient as a sensitive indicator of diastolic cardiac dysfunction in patients with childhood cancer after anthracycline therapy.
Shigemitsu S; Takahashi K; Yazaki K; Kobayashi M; Yamada M; Akimoto K; Tamaichi H; Fujimura J; Saito M; Nii M; Itatani K; Shimizu T
Heart Vessels; 2019 Jun; 34(6):992-1001. PubMed ID: 30673819
[TBL] [Abstract][Full Text] [Related]
11. Assessing anthracycline-treated childhood cancer survivors with advanced stress echocardiography.
Ryerson AB; Border WL; Wasilewski-Masker K; Goodman M; Meacham L; Austin H; Mertens AC
Pediatr Blood Cancer; 2015 Mar; 62(3):502-8. PubMed ID: 25393686
[TBL] [Abstract][Full Text] [Related]
12. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Cheuk DK; Sieswerda E; van Dalen EC; Postma A; Kremer LC
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008011. PubMed ID: 27552363
[TBL] [Abstract][Full Text] [Related]
13. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
[TBL] [Abstract][Full Text] [Related]
14. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
[TBL] [Abstract][Full Text] [Related]
15. Impaired Left Ventricular Reserve in Childhood Cancer Survivors Treated With Anthracycline Therapy.
Kaneko S; Tham EB; Haykowsky MJ; Spavor M; Khoo NS; Mackie AS; Smallhorn JF; Thompson RB; Nelson MD
Pediatr Blood Cancer; 2016 Jun; 63(6):1086-90. PubMed ID: 26844944
[TBL] [Abstract][Full Text] [Related]
16. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR
BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235
[TBL] [Abstract][Full Text] [Related]
17. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
[TBL] [Abstract][Full Text] [Related]
18. Assessment of anthracycline-induced cardiotoxicity in childhood cancer survivors during long-term follow-up using strain analysis and intraventricular pressure gradient measurements.
Hosono Y; Takahashi K; Shigemitsu S; Akimoto S; Ifuku M; Yazaki K; Wakatsuki H; Yaguchi A; Tomita O; Fujimura J; Saito M; Yoneoka D; Shimizu T
Heart Vessels; 2024 Feb; 39(2):105-116. PubMed ID: 37973710
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Cardiac Biomarkers Assessment in Combination with Myocardial 2D Strain Echocardiography for Early Detection of Anthracycline-Related Cardiac Toxicity.
Mahjoob MP; Sheikholeslami SA; Dadras M; Mansouri H; Haghi M; Naderian M; Sadeghi L; Tabary M; Khaheshi I
Cardiovasc Hematol Disord Drug Targets; 2020; 20(1):74-83. PubMed ID: 31513000
[TBL] [Abstract][Full Text] [Related]
20. Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.
Toro-Salazar OH; Gillan E; O'Loughlin MT; Burke GS; Ferranti J; Stainsby J; Liang B; Mazur W; Raman SV; Hor KN
Circ Cardiovasc Imaging; 2013 Nov; 6(6):873-80. PubMed ID: 24097420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
